…
| Funding Opportunity Number: |
RFA-HL-14-012 |
| Opportunity Category: |
Discretionary |
| Funding Instrument Type: |
Grant |
| Category of Funding Activity: |
Health |
| CFDA Number: |
93.233
93.350
93.837
93.838 |
| Eligible Applicants |
Small businesses |
| Agency Name: |
HHS-NIH11 |
| Closing Date: |
Jun 19, 2015 |
| Award Ceiling: |
|
| Expected Number of Awards: |
|
| Creation Date: |
Apr 16, 2013 |
| Funding Opportunity Description: |
The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is to de-risk these technologies so that development can continue with private funding after NHLBI support ends; therefore, applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required. |
|
Read more
{iframe}http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-012.html{/iframe}
